Ocugen, Inc. (OCGN) — Analyst outlook / Analyst consensus target is. Based on 5 analyst ratings, the consensus is bullish — 4 Buy, 1 Hold.
The consensus price target is $5.00 (low: $3.50, high: $6.00), representing an upside of 177.8% from the current price $1.80.
Analysts estimate Earnings Per Share (EPS) of $-0.20 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.20 vs est $-0.20 (beat +0%). 2025: actual $-0.23 vs est $-0.23 (missed -0.5%). Analyst accuracy: 100%.
OCGN Stock — 12-Month Price Forecast
$5.00
▲ +177.78% Upside
Average Price Target
Based on 5 Wall Street analysts offering 12-month price targets for Ocugen, Inc., the average price target is $5.00, with a high forecast of $6.00, and a low forecast of $3.50.
The average price target represents a +177.78% change from the last price of $1.80.
Highest Price Target
$6.00
Average Price Target
$5.00
Lowest Price Target
$3.50
OCGN Analyst Ratings
Buy
Based on 5 analysts giving stock ratings to Ocugen, Inc. in the past 3 months
EPS Estimates — OCGN
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$0.20
vs Est –$0.20
▼ 0.0% off
2025
Actual –$0.23
vs Est –$0.23
▼ 0.5% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — OCGN
81%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.004B
vs Est $0.004B
▲ 10.7% off
2025
Actual $0.004B
vs Est $0.006B
▼ 26.9% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
